AGOSTINELLI, CLAUDIO
 Distribuzione geografica
Continente #
NA - Nord America 15.018
AS - Asia 11.968
EU - Europa 9.170
SA - Sud America 776
Continente sconosciuto - Info sul continente non disponibili 733
AF - Africa 730
OC - Oceania 17
Totale 38.412
Nazione #
US - Stati Uniti d'America 14.746
SG - Singapore 3.292
CN - Cina 3.080
VN - Vietnam 3.020
GB - Regno Unito 2.313
IT - Italia 1.583
DE - Germania 1.235
SE - Svezia 995
HK - Hong Kong 809
IN - India 673
FR - Francia 642
BR - Brasile 542
RU - Federazione Russa 531
UA - Ucraina 420
IE - Irlanda 336
ZA - Sudafrica 265
JP - Giappone 203
NL - Olanda 186
FI - Finlandia 169
BD - Bangladesh 164
CH - Svizzera 155
EE - Estonia 153
CI - Costa d'Avorio 152
KR - Corea 148
CA - Canada 137
TG - Togo 130
AR - Argentina 102
BG - Bulgaria 75
ID - Indonesia 71
AT - Austria 63
JO - Giordania 63
PH - Filippine 58
TR - Turchia 58
TH - Thailandia 53
MX - Messico 50
NG - Nigeria 49
PL - Polonia 49
BE - Belgio 48
SC - Seychelles 45
PK - Pakistan 37
ES - Italia 36
IQ - Iraq 34
EC - Ecuador 33
TW - Taiwan 33
IR - Iran 32
HR - Croazia 28
CL - Cile 27
CO - Colombia 26
LB - Libano 25
LU - Lussemburgo 25
JM - Giamaica 24
LT - Lituania 23
SA - Arabia Saudita 23
GR - Grecia 22
UZ - Uzbekistan 22
EG - Egitto 14
VE - Venezuela 14
MY - Malesia 13
AU - Australia 12
MA - Marocco 12
PY - Paraguay 12
CR - Costa Rica 11
HU - Ungheria 10
PT - Portogallo 10
RO - Romania 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
IL - Israele 9
KE - Kenya 9
PE - Perù 9
DZ - Algeria 8
AL - Albania 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
GT - Guatemala 7
NP - Nepal 7
UY - Uruguay 7
HN - Honduras 6
NI - Nicaragua 6
PS - Palestinian Territory 6
SK - Slovacchia (Repubblica Slovacca) 6
TT - Trinidad e Tobago 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BS - Bahamas 5
LV - Lettonia 5
AO - Angola 4
DK - Danimarca 4
OM - Oman 4
SI - Slovenia 4
BO - Bolivia 3
BY - Bielorussia 3
GH - Ghana 3
GP - Guadalupe 3
KG - Kirghizistan 3
KW - Kuwait 3
MD - Moldavia 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
Totale 37.623
Città #
Singapore 2.196
Southend 2.002
Ashburn 1.480
Fairfield 1.437
Chandler 899
Hong Kong 756
San Jose 742
Woodbridge 713
Houston 704
Wilmington 664
Ho Chi Minh City 647
Seattle 612
Hanoi 555
Princeton 546
Cambridge 503
Ann Arbor 457
Beijing 437
Santa Clara 424
Dong Ket 401
Boardman 344
Bologna 336
Dublin 335
Council Bluffs 317
Hefei 287
Lauterbourg 271
Nanjing 238
Los Angeles 230
Westminster 211
Jacksonville 201
New York 201
Padova 182
Tokyo 180
Dallas 153
Abidjan 152
Bremen 137
Helsinki 137
Berlin 134
Milan 134
Lomé 129
Bern 126
Jinan 120
Seoul 116
Buffalo 115
Saint Petersburg 114
Da Nang 108
Shenyang 99
Haiphong 93
Redondo Beach 90
Nanchang 86
Redmond 86
London 83
Changsha 78
San Diego 77
Frankfurt am Main 75
Hebei 75
São Paulo 75
Sofia 74
Guangzhou 72
Chicago 70
Hyderabad 69
Phoenix 65
Tianjin 65
Mülheim 64
Amman 61
Hangzhou 61
Medford 59
Johannesburg 58
Zhengzhou 57
Jiaxing 56
Falls Church 51
Rome 49
Brussels 47
Abeokuta 46
Orem 44
Munich 43
Shanghai 43
Turin 41
Haikou 40
Montreal 40
Redwood City 40
Toronto 40
Yubileyny 39
Jakarta 38
Vienna 37
Dearborn 35
Taizhou 35
Can Tho 34
Warsaw 34
Norwalk 33
San Venanzo 33
The Dalles 33
Des Moines 32
Hải Dương 32
San Francisco 31
Ningbo 30
Nuremberg 29
Olalla 29
Taiyuan 29
Bengaluru 28
Chennai 28
Totale 24.074
Nome #
ANALYSIS OF THE CODING GENOME OF SPLENIC MARGINAL ZONE LYMPHOMA REVEALS MUTATIONAL ACTIVATION OF NOTCH2 AND OTHER PATHWAYS REGULATING MARGINAL ZONE DIFFERENTIATION 331
Genomic Profiling of Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets 306
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 288
Biology and treatment of follicular lymphoma. 285
Gastric MALT Lymphoma in a Sleeve Gastrectomy Specimen: Case Report and Literature Review 281
Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target 276
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 270
The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study 261
Prevention of large-scale implementation of unnecessary and expensive predictive tests in Hodgkin's lymphoma – Authors' reply 258
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified 256
CDKN1B/p27 expression in peripheral T cell lymphoma not otherwise specified. 254
The evolution of clonality testing in the diagnosis and monitoring of hematological malignancies 246
IFI16 expression is related to selected transcription factors during B-cell differentiation 232
Large cell non Hodgkin’s lymphoma: what is new in the WHO classification? 230
Dissection of DLBCL Microenvironment Provides a Gene Expression-Based Predictor of Survival Applicable to Formalin-Fixed Paraffin-Embedded Tissue 227
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients. 225
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 225
A patient with plasmablastic lymphoma achieving long-term complete remission after thalidomide-dexamethasone induction and double autologous stem cell transplantation: a case report 225
An isolated penile mass in a young adult turned out to be a primary marginal zone lymphoma of the penis. A case report and a review of literature. 220
A novel patient-derived tumorgraft model with TRAF1-ALK anaplastic large-cell lymphoma translocation 219
Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1 218
Constitutive activation of the DNA damage response pathway as a novel therapeutic target in diffuse large B-cell lymphoma 213
Expression of CD52 in peripheral T-cell lymphoma. 211
RALE051: a novel established cell line of sporadic Burkitt lymphoma 210
Aberrant expression of CD10 and BCL6 in mantle cell lymphoma 210
ETV6::ABL1-Positive Myeloid Neoplasm: A Case of a Durable Response to Imatinib Mesylate without Additional or Previous Treatment 208
FIRMA MOLECOLARE E SUOI USI COME AGENTE DIAGNOSTICO 204
A 3-gene signature based on MYC, BCL-2 and NFKBIA improves risk stratification in diffuse large B-cell lymphoma 204
Distinctive histogenesis and immunological microenvironment based on transcriptional profiles of Follicular dendritic cell sarcomas 203
MINIMAL RESIDUAL DISEASE (MRD) EVALUATION IN LYMPHOMAS WITHIN THE FIL (FONDAZIONE ITALIANA LINFOMI) MRD NETWORK: INTER-LABORATORY REPRODUCIBILITY ON BORDERLINE SAMPLES 200
Systemic Epstein-Barr-virus-positive T cell lymphoproliferative childhood disease in a 22-year-old Caucasian man: A case report and review of the literature 200
Selective apoptosis of monocytes and monocyte-derived DCs induced by bortezomib (Velcade). 198
CD30 expression in peripheral T-cell lymphomas 197
Molecular Profiling Improves Classification and Prognostication of Nodal Peripheral T-Cell Lymphomas: Results of a Phase III Diagnostic Accuracy Study 197
Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition 197
Erythrophagocytosis by neoplastic cells in a patient with myelodysplastic syndrome 196
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 196
Histopathology of B-cell chronic lymphocytic leukemia. 193
Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway. 192
Pitfalls in diagnosis: primary mediastinal non-seminomatous germ cell tumour with bone marrow metastasis showing melanoma-like phenotype. 189
CDKN1B/P27 expression in peripheral T-cell lymphoma not otherwise specified 187
A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma. 187
Two Different Extranodal Lymphomas in an HIV+ Patient: A Case Report and Review of the Literature 187
Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival 186
Photodynamic therapy: An option in mycosis fungoides 186
Benign TdT-positive cells in pediatric and adult lymph nodes: a potential diagnostic pitfall 185
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphoma 184
Beyond NPM-anaplastic lymphoma kinase driven lymphomagenesis 184
Post-radiotherapy vascular lesions of the breast: immunohistochemical and molecular features of 74 cases with long term follow up and literature review 184
BCL-2 Expression in Primary Cutaneous Follicle Center B-Cell Lymphoma and Its Prognostic Role 184
Pathobiology of hodgkin lymphoma. 183
Anaplastic Large Cell Lymphoma: a critical reappraisal 182
Immune microenvironment profiling of gastrointestinal stromal tumors (GIST) shows gene expression patterns associated to immune checkpoint inhibitors response 182
The emerging role of GSK-3β in the pathobiology of classical Hodgkin lymphoma 181
BCL10 expression in peripheral T-Cell lymphoma not otherwise specified. 180
BCL10 down-regulation in peripheral T-cell lymphomas. 180
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypes 178
Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score. 177
Blastic plasmacytoid dendritic cell neoplasm (BPDCN): the cutaneous sanctuary - Neoplasia a cellule dendritiche plasmocitoidi blastiche: il santuario cutaneo 177
Linfomi a cellule T periferiche NAS: nuovo indice prognostico. 175
Leukocytoclastic vasculitis associated with hairy cell leukemia at diagnosis: A case report and review of the literature 175
Characterization of a new monoclonal antibody against PAX5/BASP in 1525 paraffin-embedded human and animal tissue samples. 174
Hsa-miR-15a and Hsa-miR-16-1 Expression Is Not Related to Proliferation Centers Abundance and Other Prognostic Factors in Chronic Lymphocytic Leukemia 174
Cytoplasmic mutated nucleophosmin (NPM1) in blast crisis of chronic myeloid leukaemia. 173
Primary cardiac non-Hodgkin lymphoma presenting with atrial flutter and pericardial effusion. 172
Chronic inflammation, including Autoimmunity, and Lymphomagenesis. 172
PD-1 (PDCD1) promoter methylation in Merkel cell carcinoma: prognostic relevance and relationship with clinico-pathological parameters 172
Pathobiology of anaplastic large cell lymphoma. 171
Another look at follicular lymphoma: immunophenotypic and molecular analyses identify distinct follicular lymphoma subgroups 171
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 170
Myeloid nuclear differentiation antigen: an aid in differentiating lymphoplasmacytic lymphoma and splenic marginal zone lymphoma in bone marrow biopsies at presentation 170
Bilateral orbital Erdheim-Chester disease treated with 12 weekly administrations of VNCOP-B chemotherapy: a case report and a review of literature. 170
The Prognostic value of tumor and microenvironment markers in classifical Hodgkin lymphoma (CHL) patients. 170
Cutaneous adverse-events in patients treated with Ibrutinib 170
Histological findings in patients with suspected mediastinal lymphoma relapse according to positive positron emission tomography scan during follow-up: a large retrospective analysis in 96 patients 169
A case of primary MALT lymphoma of the endometrium presenting as an asymptomatic polyp. 167
Intrafollicular Epstein-Barr virus-positive large B cell lymphoma. A variant of “germinotropic” lymphoproliferative disorder 167
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia 167
Granulomatous tattoo reaction in a nivolumab-treated patient 166
Potential pathogenetic implications of cyclooxygenase-2 overexpression in B chronic lymphoid leukemia cells. 163
Long-term durable response to lenalidomide in a patient with hepatic epithelioid hemangioendothelioma 163
Correction: Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified (Modern Pathology, (2020), 33, 2, (179-187), 10.1038/s41379-019-0279-8) 162
Vascular endothelial growth factor A (VEGFA) expression in mycosis fungoides 162
Immune-infiltrate characterization in localized osteosarcoma patients treated within protocol ISG-OS1. 162
Pathobiology of ALK-negative anaplastic large cell lymphoma. 161
Fading With Time of PD-L1 Immunoreactivity in Non-Small Cells Lung Cancer Tissues: A Methodological Study 160
Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter's transformation 159
CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma 159
Droplet digital polymerase chain reaction for the assessment of disease burden in hairy cell leukemia 158
BCL10 expression in peripheral T-cell lymphoma not otherwise specified. 157
Prognostic factors in a multicentre study of 247 atypical pulmonary carcinoids. 156
Pathobiology of Epstein-Barr virus-driven peripheral T-cell lymphomas 155
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma 154
Primary effusion lymphoma associated with Human Herpes Virus-8 and Epstein Barr virus in an HIV-infected woman from Kampala, Uganda: a case report. 153
Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B 153
CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies? 153
Cytoplasmic nucleophosmin is not detected in blastic plasmacytoid dendritic cell neoplasm. 152
Peripheral T-cell lymphomas not otherwise specified correspond to distinct mature T-cell populations basing on the global gene expression profile. 152
The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas. 151
Primary cutaneous lymphomas: a reprisal 151
Totale 19.336
Categoria #
all - tutte 111.275
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.275


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.785 0 151 240 284 436 242 80 282 208 351 889 622
2022/20234.424 539 603 251 599 335 334 132 243 711 104 320 253
2023/20241.240 64 229 116 105 109 227 89 82 43 87 36 53
2024/20254.668 232 878 447 368 664 232 404 144 55 229 176 839
2025/202612.008 826 975 1.090 1.010 1.405 716 1.263 414 2.426 1.038 462 383
2026/2027919 407 512 0 0 0 0 0 0 0 0 0 0
Totale 38.412